UC San Diego to advance stem cell therapies in new space station lab – – KUSI

April 9, 2020 Posted: April 9, 2020 Updated: 5:22 PM KUSI Newsroom SAN DIEGO (KUSI) UC San Diego and Space Tango receive NASA award to develop first dedicated stem cell research laboratory within the International Space Station. UCSDs website reports, A three-year, nearly $5 million award from NASA will allow researchers at the Sanford Stem Cell Clinical Center at UC San Diego Health, Sanford Consortium for Regenerative Medicine and their partners at Space Tango to develop a new integrated space stem cell orbital research laboratory within the International Space Station (ISS) and launch three collaborative research projects within it. Stem cells self-renew, generating more stem cells, and specialize into tissue-specific cells, such as blood, brain and liver cells, making them ideal for biological studies far from Earths resources.

Read more
Mount Sinai Leading the Way in Innovative Stem Cell Therapy for COVID-19 Patients – Newswise

Newswise (New York, NY April 9, 2020) Mount Sinai Health System is the first in the country to use an innovative allogeneic stem cell therapy in COVID-19 patients and will play a central role in developing and conducting a rigorous clinical trial for patients with severe acute respiratory distress syndrome, the breathing illness that afflicts people who have severe cases of COVID-19.

Read more
More Coronavirus Vaccines and Treatments Move Toward Human Trials – The New York Times

As the coronavirus pandemic spreads at unprecedented rates, invading the lungs of people of all ages, ethnicities and medical histories, companies are ratcheting up their efforts to fight the disease with accelerated schedules for creating new vaccines, and beginning clinical trials for potential treatments. On Wednesday, Novavax, a Maryland-based biotech company, said it would begin human trials in Australia in mid-May for its vaccine candidate. Novavax is one of more than two dozen companies that have announced promising vaccine programs that are speeding through the early stages of testing unlike ever before.

Read more
Hackensack Meridian Health Studying the Blood of COVID-19 Survivors – P&T Community

NUTLEY, N.J., April 10, 2020 /PRNewswire/ --Researchers and clinical experts at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, are looking into the blood of COVID-19 survivors, as a potential treatment for current COVID-19 patients. The work will scrutinize the antibodies within the serum of the surviving patients, in an attempt to discover more about the disease, and perhaps develop new ways to fight it

Read more
COVID-19 Impact on Stem Cell Media Market Identify Which Types of Companies Could Potentially Benefit or Loose out From the Impact of COVID-19 -…

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Stem Cell Media Market which would mention How the Covid-19 is Affecting the Stem Cell Media Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Stem Cell Media Players to Combat Covid-19 Impact. The Global Stem Cell Media Market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market

Read more
Stem Cell Therapy Market Size 2020 | Top Companies, Growth Overview, Technology, Latest Trends and Forecast 2026 – Curious Desk

New Jersey, United States:The new report has been added by Verified Market Research to provide a detailed overview of the Stem Cell Therapy Market. The study will help to better understand the Stem Cell Therapy industry competitors, the sales channel, Stem Cell Therapy growth potential, potentially disruptive trends, Stem Cell Therapy industry product innovations and the value / volume of size market (regional / national level, Stem Cell Therapy- Industrial segments), market share of the best actors / products. Information has been added to the report to provide a realistic view of the industry based on data from Stem Cell Therapy manufacturers, i.e.

Read more
ReNeuron jumps as it agrees research deal with unnamed "major pharmaceutical company" to develop emerging cell technology – Proactive…

() shares jumped 12% higher on Tuesday after the firm revealed it hassigned a research agreement with an unnamed major pharmaceutical company to develop the formers exosome technology. In very simple laymans terms, exosomes are used by cells to communicate and are released as tiny nano-bubbles into the body to do so

Read more
Celularity and Infectious Disease Research Institute will try out COVID-19 cell therapy – GeekWire

Celularitys subsidiary, LifebankUSA, maintains a repository of placental and cord blood, containing stem cells for potential therapeutic use. (LifebankUSA / Robert Hariri via Twitter) Seattles Infectious Disease Research Institute and a New Jersey company called Celularity have been cleared by the Food and Drug Administration to start trials of an experimental cell-based therapy for COVID-19

Read more